Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacek Jassem

Showing results (31-40 of 274) with videos related to

Pageof 28
Sort By:
Przeglad Lekarski|June 22, 2006
[Adjuncts to surgery in cervical cancer]Krystyna Serkies, Ewa Wegrzynowicz, Jacek Jassem
Acta Oncologica (Stockholm, Sweden)|August 30, 2006
Clinical relevance of hemoglobin level in cervical cancer patients administered definitive radiotherapyKrystyna Serkies, Andrzej Badzio, Jacek Jassem
Contemporary Oncology (Poznan, Poland)|June 22, 2013
The role of hormonal factors and endocrine therapy in ovarian cancerKrystyna Serkies, Marcin Sinacki, Jacek Jassem
Frontiers in Oncology|February 19, 2024
Neurotoxicity-sparing radiotherapy for brain metastases in breast cancer: a narrative reviewDagmara Buczek, Renata Zaucha, Jacek Jassem
Cancer Treatment Reviews|October 27, 2018
Management of brain metastases in non-small cell lung cancer in the era of tyrosine kinase inhibitorsAnna Wrona, Rafał Dziadziuszko, Jacek Jassem
Critical Reviews in Oncology/Hematology|September 20, 2005
Epoetin beta therapy in patients with solid tumoursPaolo Pronzato, Jacek Jassem, Jose Mayordomo
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|July 7, 2005
[The role of radiotherapy in the management of esophageal cancer]Krystyna Serkies, Andrzej Badzio, Jacek Jassem
Archives of Gynecology and Obstetrics|March 4, 2011
Paclitaxel and cisplatin chemotherapy for ovarian cancer during pregnancy: case report and review of the literatureKrystyna Serkies, Ewa Węgrzynowicz, Jacek Jassem
Ginekologia Polska|September 16, 2016
Systemic therapy for endometrial stromal sarcomas: current treatment optionsKrystyna Serkies, Ewa Pawłowska, Jacek Jassem
Translational Lung Cancer Research|May 20, 2021
Combining radiotherapy with targeted therapies in non-small cell lung cancer: focus on anti-EGFR, anti-ALK and anti-angiogenic agentsAnna Wrona, Rafał Dziadziuszko, Jacek Jassem
Pageof 28

Showing results (31-40 of 274) with videos related to

Sort By:
Pageof 28
Przeglad Lekarski|June 22, 2006
[Adjuncts to surgery in cervical cancer]Krystyna Serkies, Ewa Wegrzynowicz, Jacek Jassem
Acta Oncologica (Stockholm, Sweden)|August 30, 2006
Clinical relevance of hemoglobin level in cervical cancer patients administered definitive radiotherapyKrystyna Serkies, Andrzej Badzio, Jacek Jassem
Contemporary Oncology (Poznan, Poland)|June 22, 2013
The role of hormonal factors and endocrine therapy in ovarian cancerKrystyna Serkies, Marcin Sinacki, Jacek Jassem
Frontiers in Oncology|February 19, 2024
Neurotoxicity-sparing radiotherapy for brain metastases in breast cancer: a narrative reviewDagmara Buczek, Renata Zaucha, Jacek Jassem
Cancer Treatment Reviews|October 27, 2018
Management of brain metastases in non-small cell lung cancer in the era of tyrosine kinase inhibitorsAnna Wrona, Rafał Dziadziuszko, Jacek Jassem
Critical Reviews in Oncology/Hematology|September 20, 2005
Epoetin beta therapy in patients with solid tumoursPaolo Pronzato, Jacek Jassem, Jose Mayordomo
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|July 7, 2005
[The role of radiotherapy in the management of esophageal cancer]Krystyna Serkies, Andrzej Badzio, Jacek Jassem
Archives of Gynecology and Obstetrics|March 4, 2011
Paclitaxel and cisplatin chemotherapy for ovarian cancer during pregnancy: case report and review of the literatureKrystyna Serkies, Ewa Węgrzynowicz, Jacek Jassem
Ginekologia Polska|September 16, 2016
Systemic therapy for endometrial stromal sarcomas: current treatment optionsKrystyna Serkies, Ewa Pawłowska, Jacek Jassem
Translational Lung Cancer Research|May 20, 2021
Combining radiotherapy with targeted therapies in non-small cell lung cancer: focus on anti-EGFR, anti-ALK and anti-angiogenic agentsAnna Wrona, Rafał Dziadziuszko, Jacek Jassem
Pageof 28